Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (11)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2022

  1. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular Markers

    Translational Stroke Research, Vol. 13, Núm. 2, pp. 228-237

  3. The Smoking Paradox in Stroke Patients Under Reperfusion Treatment Is Associated With Endothelial Dysfunction

    Frontiers in Neurology, Vol. 13

  4. Treatments Against Glutamatergic Excitotoxicity in Ischemic Stroke

    Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 1-25

2021

  1. New approaches in nanomedicine for ischemic stroke

    Pharmaceutics, Vol. 13, Núm. 5

  2. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2020

  1. Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

    Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663

  2. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 11, pp. 2103-2114

2018

  1. Trends in stroke outcomes in the last ten years in a European tertiary hospital

    BMC Neurology, Vol. 18, Núm. 1